Skip to main content

Advertisement

Table 1 Comparison of patients’ demographic and clinical features before treatment

From: The efficacy, acceptability, and safety of five atypical antipsychotics in patients with first-episode drug-naïve schizophrenia: a randomized comparative trial

Groups N Gender (M/F, n) Age (years) Marital status (M/U/D) Duration of illness (months) Baseline BPRS
Ari. 39 21/18 26.31 ± 8.09 16/22/1 10.29 ± 13.29 54.49 ± 10.46
Ris. 43 22/21 32.37 ± 8.45 26/15/2 10.34 ± 15.67 54.12 ± 10.21
Que. 39 18/21 28.77 ± 8.31 19/17/3 4.41 ± 8.01 56.72 ± 11.46
Ola. 35 17/18 25.54 ± 6.93 15/19/1 9.29 ± 13.22 57.40 ± 14.90
Zip. 19 3/16 22.26 ± 5.41 7/12/0 7.31 ± 12.96 57.79 ± 15.34
χ 2/F   8.49 7.38 8.36 1.45 0.65
P value   > 0.05 < 0.01 > 0.05 > 0.05 > 0.05
  1. Values are represented as mean ± SD; N: number of patients; M/F: male/female; Ari.: aripiprazole; Ris.: risperidone; Que.: quetiapine; Ola.: olanzapine; Zip.: ziprasidone. M: married; U: unmarried; D: divorced